scispace - formally typeset
D

David Beach

Researcher at Cold Spring Harbor Laboratory

Publications -  207
Citations -  56103

David Beach is an academic researcher from Cold Spring Harbor Laboratory. The author has contributed to research in topics: Cyclin-dependent kinase 1 & Cell cycle. The author has an hindex of 97, co-authored 204 publications receiving 54757 citations. Previous affiliations of David Beach include Howard Hughes Medical Institute & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Cdc25 cell-cycle phosphatase as a target of c- myc

TL;DR: Findings indicate that cdc25A is a physiologically relevant transcriptional target of c-myc, a proto-oncogene that can promote either oncogenic transformation or apoptosis in cells depleted of growth factor.
Journal ArticleDOI

Human D-type cyclin

TL;DR: A cDNA library prepared from a human glioblastoma cell line has been introduced into a budding yeast strain that lacks CLN1 and CLN2 and is conditionally deficient for CLN3 function and rescued a gene that is called cyclin D1, related to A-, B-, andCLN-type cyclins, but appears to define a new subclass within the cyclin gene family.
Journal ArticleDOI

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair

TL;DR: It is shown that p21 does not block PCNA-dependent nucleotide-excision repair, in contrast to its inhibition of simian virus 40 DNA replication, and the short gap-filling DNA synthesis by PC NA-dependent DNA polymerases δ and ɛ is less sensitive to inhibition by p21 than is long primer-extension synthesis.
Journal ArticleDOI

mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2

TL;DR: It is shown here that a related 66 kd kinase, called mik1, acts redundantly with wee1 in the negative regulation of cdc2 in S, both in strains undergoing mitotic lethality and in those that are viable owing to a compensating mutation within cDC2.
Journal ArticleDOI

p21-containing cyclin kinases exist in both active and inactive states.

TL;DR: It is shown that p21-containing complexes exist in both catalytically active and inactive forms, which challenges the current view that active cyclin kinases function only in the binary state and reveals the subtlety with which tumor-suppressor proteins modulate the cell cycle.